Time-of-Arrival States

Although one can show formally that a time-of-arrival operator cannot exist, one can modify the low momentum behaviour of the operator slightly so that it is self-adjoint. We show that such a modification results in the difficulty that the eigenstates are drastically altered. In an eigenstate of the modified time-of-arrival operator, the particle, at the predicted time-of-arrival, is found far away from the point of arrival with probability 1/2.Comment: 15 pages, 2 figure

The Time-Energy Uncertainty Relation

The time energy uncertainty relation has been a controversial issue since the advent of quantum theory, with respect to appropriate formalisation, validity and possible meanings. A comprehensive account of the development of this subject up to the 1980s is provided by a combination of the reviews of Jammer (1974), Bauer and Mello (1978), and Busch (1990). More recent reviews are concerned with different specific aspects of the subject. The purpose of this chapter is to show that different types of time energy uncertainty relation can indeed be deduced in specific contexts, but that there is no unique universal relation that could stand on equal footing with the position-momentum uncertainty relation. To this end, we will survey the various formulations of a time energy uncertainty relation, with a brief assessment of their validity, and along the way we will indicate some new developments that emerged since the 1990s.Comment: 33 pages, Latex. This expanded version (prepared for the 2nd edition of "Time in quantum mechanics") contains minor corrections, new examples and pointers to some additional relevant literatur

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362